Shares of Spero Therapeutics gained after the company and GSK ended their trial for a treatment for complicated urinary tract infections early after it met its primary endpoint. The stock more than ...

Spero Therapeutics and partner GSK are stopping a late-stage trial of an experimental oral drug for complicated urinary tract ...

TQ Therapeutics GmbH (TQx) has acquired Juno Therapeutics GmbH, a cell therapy company, through a share purchase agreement.

Spero Therapeutics (SPRO) stock jumps as GSK (GSK) partnered oral UTI treatment, tebipenem HBr, succeeds in a pivotal Phase 3 ...

A development deal with Biogen Inc. could eventually bring City Therapeutics Inc. about $1 billion in milestone payments. Privately held City Therapeutics is getting $46 million in the deal. That ...

Eli Lilly is expanding its efforts to advance next-generation pain medications. | Eli Lilly is expanding its efforts to ...

Axsome Therapeutics and Hetero Labs agreed to settle to resolve patent litigation claims. The litigation, which is pending in a New Jersey district court, resulted from Hetero submitting an ...

The European Medicines Agency (EMA) has validated the marketing authorisation application (MAA) submitted by Soleno ...

Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the ...

Alaunos Therapeutics ( ($TCRT) ) just unveiled an announcement. On May 19, 2025, Alaunos Therapeutics entered into an equity purchase agreement ...

Soleno Therapeutics, Inc. (NASDAQ:SLNO) has achieved a major regulatory milestone as the European Medicines Agency (EMA) ...